Form 4: GoodRx Holdings Director Douglas Joseph Hirsch Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


Director Douglas Joseph Hirsch reports transactions involving GoodRx Holdings Class A Common Stock, including acquisitions of deferred and restricted stock units, as well as holdings through grantor retained annuity trusts.

Summary

  • On October 26, 2024, Douglas Joseph Hirsch, a director of GoodRx Holdings, Inc., reported changes in beneficial ownership of Class A Common Stock.
  • Hirsch acquired 797 deferred stock units, vesting monthly over three months starting October 31, 2024, and settling no later than December 31, 2027.
  • He also acquired 20,597 restricted stock units, vesting fully on the earlier of June 6, 2025, or the date of the 2025 Annual Meeting of Stockholders.
  • Additionally, Hirsch was granted 61,563 restricted stock units, vesting in three equal annual installments beginning October 26, 2025.
  • Hirsch serves as the sole trustee and annuitant of the DH 2024 GRAT, which holds 2,632,721 shares of Class A Common Stock.
  • Chona Hirsch, his spouse, serves as the sole trustee and annuitant of the CH 2024 GRAT, also holding 2,632,721 shares of Class A Common Stock; Douglas Hirsch disclaims beneficial ownership of these shares.
  • Following these transactions, Hirsch directly owns 147,946 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating stock transactions by a director, which is neither overtly positive nor negative.

Positives

  • The acquisition of deferred and restricted stock units by a director signals confidence in the company's future performance.
  • The vesting schedules of the restricted stock units incentivize continued service and alignment with shareholder interests.

Future Outlook

The vesting schedules of the stock units suggest an expectation of continued service and company performance over the next several years.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. These filings are closely watched by investors for signals about management's confidence in the company.

Comparison to Industry Standards

  • Stock-based compensation is a common practice in the tech industry to attract and retain talent.
  • Vesting schedules are typically structured to align employee and shareholder interests over a multi-year period.
  • Grantor Retained Annuity Trusts (GRATs) are a common estate planning tool used by high-net-worth individuals to transfer assets while minimizing gift and estate taxes.

Stakeholder Impact

  • Shareholders may view the director's stock acquisitions as a positive sign of confidence in the company.
  • The vesting schedules of the stock units incentivize the director to remain with the company and work towards its success.

Key Dates

DateDescription
10/26/2024Date of the reported transactions, including acquisition of deferred and restricted stock units.
10/31/2024Start date for monthly vesting of deferred stock units.
06/06/2025Potential vesting date for restricted stock units.
2025 Annual Meeting of StockholdersPotential vesting date for restricted stock units.
10/26/2025Start date for annual vesting of restricted stock units.
12/31/2027Latest possible settlement date for deferred stock units.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.